证券代码：000813 证券简称：德展健康 公告编号：2025-046 二、其他事项说明 德展大健康股份有限公司（以下简称"公司"）分别于 2024 年 7 月 1 日及 2024 年 7 月 18 日召开了第八届董事会第二十七次会议和 2024 年第一次临时股 东大会，审议并通过了《关于回购公司股份方案的议案》。基于对公司所属行业 前景的认可、对公司未来发展的信心及公司价值的判断，为进一步增强投资者信 心，稳定投资者预期，维护广大投资者的利益，公司计划自股东大会审议通过之 日起 12 个月内使用不低于人民币 2 亿元，不超过人民币 3 亿元的自有资金，通 过集中竞价交易方式以不超过人民币 3.59 元/股的价格回购股份。本次回购的股 份将全部用于注销减少公司注册资本。具体内容详见公司于 2024 年 7 月 19 日在 《证券时报》《证券日报》《上海证券报》《中国证券报》和巨潮资讯网 （www.cninfo.com.cn）披露的《回购报告书》（公告编号：2024-036）。2025 年 1 月 23 日，公司披露了《关于增加回购股份资金来源的公告》（公告编号：2025- 005），经公司董事会同意，本轮股份 ...

德展大健康股份有限公司 关于公司控股股东开展融资融券业务的公告 控股股东新疆凯迪投资有限责任公司保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 近日，德展大健康股份有限公司（以下简称"公司"）收到公司控股股东新 疆凯迪投资有限责任公司（以下简称"凯迪投资"）发来的《关于开展融资融券 业务的告知函》，获悉其所持公司部分股份转入客户信用交易担保证券账户用于 开展融资融券业务，现将具体情况公告如下： 一、本次融资融券业务基本情况 证券代码：000813 证券简称：德展健康 公告编号：2025-045 凯迪投资与中信建投证券股份有限公司（以下简称"中信建投"）开展融资 融券业务，将其持有的公司股份 196,200,000 股无限售条件流通股转入在中信建 投开立的客户信用交易担保证券账户中充抵保证金，该部分股份的所有权未发生 转移，且凯迪投资不进行以公司股票为标的证券的融资融券交易。 上述转托管事项已于近日实施完毕，转托管前后持股情况如下： 注：尾差系四舍五入所致。 二、备查文件 （一）凯迪投资出具的《关于开展融资融 ...

Core Viewpoint - The announcement details the completion of the transfer of shares from a major shareholder, Shanghai Yueye, following a judicial auction, resulting in a new shareholder holding over 5% of the company's shares [1][2][3]. Group 1: Share Transfer Details - Shanghai Yueye successfully auctioned 124,600,010 shares, representing 5.76% of the company's total share capital, and 5.87% when excluding shares in the company's repurchase account [1][2]. - After the transfer, the new shareholder, Chen Zhiwenlong, holds 109,500,000 shares, which is 5.06% of the total share capital and 5.16% when excluding repurchased shares [3][4]. Group 2: Auction Process - The fifth auction involved 323,800,000 shares, with 124,600,010 shares successfully bid by Chen Zhiwenlong and 12 other individuals, while 199,199,990 shares remained unsold due to lack of bids [1][2]. Group 3: Regulatory Compliance - The auction and share transfer comply with relevant regulations, including the Securities Law and guidelines for shareholder share reductions [4][5]. - The new shareholder, Chen Zhiwenlong, is required to adhere to a six-month restriction on selling the acquired shares following the judicial transfer [4][5]. Group 4: Shareholder Commitments - Shanghai Yueye has made commitments regarding future transactions with the company to avoid conflicts of interest and ensure compliance with market principles [5][6]. - The commitments will remain in effect until the completion of the share disposal by Shanghai Yueye [5][6].

Core Points - The report details the equity change of Dezhang Health Co., Ltd, indicating that the information discloser, Chen Zhiwenlong, acquired shares through public auction, increasing his stake in the company [1][4][6] - The acquisition was motivated by a positive outlook on the company's development prospects and long-term investment value [4][5] - Following the acquisition, Chen Zhiwenlong holds 109,500,000 shares, representing 5.06% of the company's total share capital, and 5.16% when excluding shares in the company's repurchase account [6][8][14] Summary by Sections Section 1: Introduction - The report is prepared in accordance with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shenzhen Stock Exchange Listing Rules [1][2] Section 2: Information Discloser - Chen Zhiwenlong is identified as the information discloser, with no other significant shareholdings in other listed companies exceeding 5% [4][5] Section 3: Purpose of Equity Change - The purpose of the equity change is based on the positive outlook for the company's future and long-term investment value [4][5] - The shares were acquired during the fifth public auction held by Shanghai Yueye from May 15 to May 16, 2025 [4][5] Section 4: Method of Equity Change - The equity change occurred through a public auction, with Chen Zhiwenlong successfully acquiring 109,500,000 shares at a total price of RMB 312,075,000 [6][8] - The acquisition increased his shareholding to 5.06% of the total share capital [8][14] Section 5: Trading History - There were no other transactions involving the company's shares by the information discloser in the six months prior to the report [9] Section 6: Other Significant Matters - No other significant matters related to the equity change were disclosed [9] Section 7: Declaration - The information discloser confirms the report contains no false records, misleading statements, or significant omissions [9][10]

德展大健康股份有限公司 简式权益变动报告书 上市公司名称：德展大健康股份有限公司 股票上市地点：深圳证券交易所 股票简称：德展健康 股票代码：000813 信息披露义务人：上海岳野股权投资管理合伙企业（有限合伙） 住所：北京市朝阳区嘉泰国际大厦A座1705 通讯地址：北京市朝阳区嘉泰国际大厦A座1705 股份变动性质：股份减少 签署日期：2025年6月20日 1 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理办法》 《深圳证券交易所股票上市规则》《公开发行证券的公司信息披露内容与格式准则 第15号——权益变动报告书》等相关的法律、法规和规范性文件编制本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《深圳证券交易所 股票上市规则》《公开发行证券的公司信息披露内容与格式准则第15号——权益变动报 告书》的规定，本报告书已全面披露了信息披露义务人在德展大健康股份有限公司中拥 有权益的股份变动情况。 四、截至本报告书签署之日，除本报告 ...

证券代码：000813 证券简称：德展健康 公告编号：2025-044 德展大健康股份有限公司 关于持股 5%以上股东所持公司股份拍卖过户完成 暨新增持股 5%以上股东的公告 股东上海岳野股权投资管理合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 一、第五次拍卖相关情况 德展大健康股份有限公司（以下简称"公司"、"上市公司"）于近日收到 公司持股 5%以上股东上海岳野股权投资管理合伙企业（有限合伙）（以下简称 "上海岳野"）清算组出具的《股票拍卖过户告知函》，获悉其在第五次拍卖股 份中被竞拍成功的公司 124,600,010 股股份已于近日办理完成过户登记手续，上 述股份占公司目前总股本比例为 5.76%，占剔除公司回购专用账户股份数量后的 公司总股本比例为 5.87%1。本次拍卖股份过户完成后，竞买人陈致文龙持有公司 109,500,000 股股份（占公司目前总股本比例为 5.06%，占剔除公司回购专用账 户股份数量后的公司总股本比例为 5.16%），成为持有公司 5%以上股份的股东。 ...

德展大健康股份有限公司 简式权益变动报告书 上市公司名称：德展大健康股份有限公司 股票上市地点：深圳证券交易所 股票简称：德展健康 股票代码：000813 信息披露义务人：陈致文龙 住所：北京市朝阳区工体西路 通讯地址：北京市朝阳区工体西路 股份变动性质：股份增加（公开拍卖竞得股份） 签署日期：2025年6月20日 1 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理办法》 《深圳证券交易所股票上市规则》《公开发行证券的公司信息披露内容与格式准则 第15号——权益变动报告书》等相关的法律、法规和规范性文件编制本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反 信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《深圳证券交易所 股票上市规则》《公开发行证券的公司信息披露内容与格式准则第15号——权益变动报 告书》的规定，本报告书已全面披露了信息披露义务人在德展大健康股份有限公司中拥 有权益的股份变动情况。 四、截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务人 没有通过 ...

Core Viewpoint - The announcement indicates a significant change in shareholding structure for Dezhan Health, with a major shareholder transferring a substantial number of shares to a new investor, which may impact the company's governance and future strategies [1] Shareholding Changes - Shanghai Yueye, a shareholder holding over 5% of shares, has transferred 125 million shares, representing 5.76% of the company's total share capital and 5.87% when excluding shares in the repurchase account [1] - The new shareholder, Chen Zhiwenlong, now holds 109 million shares, accounting for 5.06% of the total share capital and 5.16% when excluding shares in the repurchase account [1]

Core Points - The announcement details the sixth public auction of shares held by a major shareholder, Shanghai Yueye, involving 199,199,990 shares of Dezhang Health, which represents 9.20% of the company's total share capital [1][2][5] - The auction was conducted on the JD Judicial Auction platform, and the results indicated that 102,045,343 shares were successfully auctioned, accounting for 4.71% of the company's total share capital [3][5] - The auction does not affect the control of the company, as Shanghai Yueye is not the controlling shareholder, and the normal operations of the company are not expected to be adversely impacted [1][7] Auction Details - The auction took place from June 9 to June 10, 2025, with a total of 199,199,990 shares available for bidding [5] - The successful bidders included individuals such as Wang Mei'er, Chen Zhiwenlong, and Zhang Shouchun, while some shares remained unsold due to lack of bids [1][2] - The total number of shares auctioned by Shanghai Yueye has reached 316,983,419, which is 14.64% of the current total share capital of the company [7] Shareholder Status - Following the auction, if all successfully auctioned shares are transferred, Shanghai Yueye's holdings will decrease to 97,154,647 shares, representing 4.49% of the total share capital [7] - Shanghai Yueye will no longer be classified as a shareholder holding more than 5% of the company's shares, prompting the company to ensure compliance with information disclosure obligations [7][8] Future Considerations - The auction process involves further steps such as payment of auction proceeds and share transfer registration, which carry some uncertainties [8] - The company will continue to monitor the auction's progress and fulfill its information disclosure responsibilities [1][8]

证券代码：000813 证券简称：德展健康 公告编号：2025-043 德展大健康股份有限公司 关于持股 5%以上股东所持公司股份第六次拍卖的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次拍卖是依据上海市第三中级人民法院（以下简称"上海市三中院"） 裁定确认的《清算方案》执行，本次公开拍卖股份为上海岳野股权投资管理合 伙企业（有限合伙）（以下简称"上海岳野"）持有的德展大健康股份有限公 司（以下简称"公司"）199,199,990 股无限售流通股（其所持公司股份总数 为 323,800,000 股，其中 124,600,010 股已被拍卖但尚未过户），占其所持公 司股份的 61.52%，占公司总股本的比例为 9.20%，占剔除公司回购专用账户股 份数量后的公司总股本比例为 9.39% 1。 2、上海岳野不是公司控股股东或实际控制人，其所持有的公司股份被 拍卖不会导致公司控制权发生变化，不会对公司的正常生产经营产生不利 影响。 3、本次拍卖的 199,199,990 股股份中的 102,045,343 股股份被竞拍成 功，竞买人为 ...